Lina Concierge Med Spa Review: Questions to Settle Before You Enroll

Before enrolling with Lina Concierge Med Spa, ask for something more concrete than a program recommendation: a written explanation of what you will receive, who will provide it, when you will be charged and how you can stop. The website offers useful detail about its telehealth process, medication categories and ongoing support. But its treatment pages and terms give materially different cancellation deadlines, making a clear answer especially important before authorizing recurring payments.

This documentary review examines public pages consulted October 19, 2026, from the perspective of an adult preparing for a consultation—not choosing an individual treatment. Lina advertises compounded semaglutide and tirzepatide, a microdose program and an oral GLP-1 option. The practical task is to separate those documented offerings from details that still need confirmation. Our starting questions for a GLP-1 program offer a broader preparation framework; here, the questions are specific to Lina’s published prices, service structure and conflicting terms.

At a glance

Advertised GLP-1 starting prices: Semaglutide Injection starts at $139/month; Tirzepatide Injection at $166/month; GLP-1 Microdose at $199/month; GLP-1 Oral at $229/month. Final pricing requires provider review.
Sources: [11] [8]
Platform rather than prescriber: Lina says independent clinicians make prescribing decisions and pharmacies prepare and dispense medications; the platform itself does not practice medicine, prescribe or dispense.
Sources: [8]
Recurring billing: The terms authorize an immediate charge for recurring monthly orders, followed by charges every 30 days until cancellation, with electronic notice 5–7 days before a scheduled transaction.
Sources: [7]
Conflicting cancellation deadlines: Treatment pages require 30 days’ notice before the next billing cycle; the terms describe disabling auto-refill at least 48 hours before the monthly processing date.
Sources: [12] [7]
Access and location: Lina advertises telehealth in all 50 states with no physical office. Its terms require patients to be physically in the same state as their shipping address during consultation and make availability subject to state rules.
Sources: [12] [7]

Start with who will actually be responsible for your care

Lina attributes its founding to Melissa Linares, NP, whom the homepage describes as a board-certified nurse practitioner in acute care. These are the website’s credential statements, not independent licensing verification. Its disclaimer draws an important operational distinction: Lina facilitates access to independent U.S.-licensed clinicians and state-licensed compounding pharmacies, while the clinicians alone conduct evaluations and decide whether to prescribe. Ask for your treating clinician’s name and professional role, rather than assuming the founder will provide your care.

The contractual identity is less clear. The terms initially name Lina Concierge Med Spa, LLC, but other clauses use Melissa Caramanica Nurse Practitioner in Acute Care PLLC. The consulted material does not explain the relationship between those names. That is a practical reason to request the legal names of the platform, medical group and dispensing pharmacy, along with which organization handles clinical complaints, payment disputes and records requests. The name on a website is not necessarily the name of every service provider.

Nationwide advertising also needs a location-specific answer. Lina says it is fully remote, serves all 50 states and has no office to visit. However, its terms require you to be physically in the same state as the shipping address during consultation, and availability remains subject to state regulations. Ask whether the particular program is available where you will actually be located, especially if you travel or use a different mailing address.

Sources: [9] [8] [12] [7]

Ask for the medicine’s identity, not just the program name

Lina’s catalog distinguishes injectable semaglutide, injectable tirzepatide, GLP-1 Microdose and GLP-1 Oral. Its semaglutide treatment page describes a weekly compounded injection. The oral listing describes a daily option but does not identify the active ingredient in the consulted catalog. The microdose material likewise does not establish the active ingredient, formulation or route. Those omissions matter: a program label is not enough to understand precisely what a clinician might prescribe or what a pharmacy would prepare.

Use the advertised prices below as starting points, not complete quotes. The homepage says plans begin at $139 per month and are confirmed after provider review. The catalog cards do not establish supply quantities, minimum commitments or prepayment requirements. Our guide to identifying the medicine before comparing an offer can help organize the request: obtain the ingredient, formulation, route, presentation, quantity and pharmacy before treating two offers as comparable.

Lina also markets tesamorelin from $299/month, sermorelin from $249/month, NAD+ from $146/month and PT-141 from $249/month. The catalog identifies NAD+ as a coenzyme rather than a peptide. These additional offerings show that the business extends beyond GLP-1 programs, but their presence is not evidence that combining services is necessary or appropriate. Ask the clinician to distinguish the proposed treatment from optional products and explain each separate charge.

Lina’s advertised GLP-1 starting prices and the details still needed
Catalog offering	Advertised starting price	Question before enrollment
Semaglutide Injection	From $139/month	What formulation, presentation and quantity does the confirmed price cover?
Tirzepatide Injection	From $166/month	What formulation, presentation and quantity does the confirmed price cover?
GLP-1 Microdose	From $199/month	What active ingredient, formulation and route are proposed?
GLP-1 Oral	From $229/month	What active ingredient and oral formulation are proposed?

Sources: [12] [11] [8]

Clarify eligibility without treating the website as a prescription

The service terms require users to be at least 18, or the age of majority in their jurisdiction if higher. Lina’s semaglutide page describes candidates as adults with a BMI of at least 27, or at least 25 with weight-related conditions. Its tirzepatide page gives the same thresholds and also discusses people who have plateaued on a single-agonist GLP-1. These are Lina’s published criteria, not a determination that any reader qualifies or should change treatment.

The semaglutide page lists exclusions including personal or family history of medullary thyroid carcinoma or MEN 2; pregnancy, breastfeeding or planned pregnancy; active pancreatitis; and untreated severe gastrointestinal disease. Bring the clinician a complete history rather than screening yourself solely against that list. NIDDK explains that medication selection involves current conditions, other medicines, family history, side effects and costs. Its general adult pharmacotherapy thresholds also differ from Lina’s published thresholds, reinforcing the need for a product-specific clinical explanation.

The microdose program has a different advertised audience: people near their goal weight, those who previously tolerated standard GLP-1 dosing poorly, and people incorporating it into a broader wellness plan. Lina excludes people with substantial weight to lose who would be better served by a standard program. Those descriptions are marketing and provider-selection statements, not clinical proof of benefit. Ask what evidence supports the exact proposed preparation and what measurable purpose the clinician expects it to serve.

Sources: [7] [12] [13] [6] [2]

Separate a quick intake from a completed clinical evaluation

The homepage describes an online assessment covering health history, weight goals and baseline measurements. Its estimated five to ten minutes refers to completing that intake—not clinician review, prescribing or delivery. Although the marketing says no appointments or clinic visits are needed, the terms still require a consultation, a clinician’s determination that a prescription product is appropriate and an issued prescription. Ask what the consultation actually involves, whether further information may be requested and when a clinician will respond.

Lina says follow-ups are scheduled as needed. The semaglutide page also advertises a dedicated provider, direct messaging through a secure patient portal and recurring concierge check-ins. That is more informative than a bare promise of support, but it does not establish a minimum visit frequency or clinician response time. Ask who reads portal messages, how the dedicated-provider arrangement works during absences and whether scheduled reviews are included regardless of how often they are needed.

General contact routes are clearer: info@linaconciergemedspa.com, a patient portal and a contact form. Published support hours are Monday through Saturday, 9 a.m. to 6 p.m. Eastern. The form promises a team response within 24 hours, but that is not a clinical-review or delivery deadline. Laboratory requirements, testing costs and interpreter availability were not established in the consulted material. Ask about those before enrollment if they could affect your ability to use the service.

Sources: [8] [7] [12] [10]

Get the first charge and the recurring charge explained together

Lina’s treatment page describes a flat-rate program covering compounded medication and a dedicated clinician, with no hidden fees, surprise consultation charges or dose-change surcharges. It says the price is confirmed at consultation. The terms describe subscription pricing as a bundle of pharmacy charges, medical-group services and platform access. Ask for one written quote identifying the product, quantity, included clinical services and delivery charges, if any, rather than relying on the starting price alone.

For recurring monthly orders, the terms authorize an immediate charge and another every 30 days until cancellation. They promise an electronic notification five to seven days before a scheduled transaction and a receipt after a successful charge. A 30-day billing interval is not necessarily a calendar month, and neither establishes the amount of medication supplied. Confirm the first processing date, refill quantity and subsequent amount. The consulted pages do not establish whether any optional payment alternatives or minimum commitments apply.

The homepage’s statement that no insurance is required does not answer whether Lina accepts coverage, submits claims or supports HSA/FSA payments. It also says patients are never charged if a program is not the right fit, while the recurring-order terms describe immediate collection. Ask exactly when payment is taken and what happens if the clinician declines treatment. Our questions beyond the monthly price provide a useful checklist for resolving these separate billing issues.

Sources: [8] [12] [7]

Resolve cancellation before the next renewal becomes relevant

The most consequential documentary conflict concerns cancellation. Treatment pages say memberships may be canceled with 30 days’ notice before the next billing cycle. The terms instead say a subscription can be canceled by switching off auto-refill in the portal up to 48 hours before the monthly processing date. Those are materially different deadlines. This review cannot determine which governs an individual purchase; ask Lina to identify the applicable rule in writing before you authorize recurring billing.

Request the exact processing date and cancellation steps, not simply assurance that cancellation is available. Under the treatment-page wording, a reminder sent five to seven days before billing would arrive after the stated 30-day notice deadline. Under the terms, that reminder could still precede the 48-hour cutoff. This difference makes the renewal notification an inadequate substitute for understanding the agreement. Keep the applicable terms and confirmation of any cancellation request for your own records.

Cancellation also does not establish a refund right. Lina says consultations, medical visits and fulfilled prescriptions are nonrefundable once services begin or medication is processed. Ask what event triggers that boundary and how it interacts with the no-charge-if-unsuitable promise. The available terms included an omitted intermediate section, so this review cannot characterize every contractual provision. Our questions to settle before the next charge can help frame a specific request rather than a general refund inquiry.

Sources: [12] [7] [8]

Identify the pharmacy and plan for delivery problems

Lina says its preparations come from licensed U.S. compounding pharmacies, but the consulted passage does not name them. Its terms also impose a significant channel restriction: purchasing a prescription-including service means waiving the ability to have that prescription filled at a pharmacy of your choice outside the platform’s accessible pharmacies. Ask for the dispensing pharmacy’s name and contact details before purchasing, and decide whether that restriction fits your needs rather than assuming a prescription can be transferred elsewhere.

The semaglutide program describes medication shipped on a structured cadence in temperature-controlled, unmarked packaging. Those statements do not establish preparation, dispatch or arrival deadlines, a carrier, shipping charges or a temperature-incident procedure. The terms additionally state that prescription products will not be dispensed in child-resistant containers. Ask what packaging you will receive, what storage information accompanies it and which organization handles damaged, delayed or missing shipments. Discreet packaging and child-resistant packaging are different features.

FDA specifically advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration, and contacting the provider or dispensing pharmacy. Lina’s advertised temperature-controlled delivery does not replace that advice. Before a shipment is sent, obtain a reachable contact for resolving a temperature concern and ask how replacement decisions are handled. The public material reviewed does not establish a replacement entitlement or reimbursement policy for such incidents, so those details require direct confirmation.

Sources: [12] [7] [1]

Read privacy promises and clinical claims at their actual scope

Lina describes its intake as secure, encrypted and HIPAA-compliant. Its terms separately say the platform is not a HIPAA covered entity, although it may act as a business associate of a pharmacy or medical group in certain circumstances. Those statements concern different roles and do not independently verify compliance. Ask which organization holds the clinical record, which privacy notice applies to it and how information entered into a marketing or intake form differs from information provided during treatment.

Advertising disclosures also deserve attention. A treatment FAQ’s broad assurance against selling or sharing data sits alongside a California notice saying some disclosures to advertising partners may count as a sale or sharing under state law. Ask which data categories are involved and what choices apply to you. This is a reason to seek a precise explanation, not a basis for concluding that all clinical information is used for advertising or that every privacy assurance is meaningless.

On medication evidence, Lina acknowledges that compounded preparations are not FDA-approved. FDA says they do not undergo its premarket review for safety, effectiveness and quality, and recommends them when an individual’s medical needs cannot be met by an approved drug. Nonapproval alone does not prove clinical inequivalence. Equally, published drug trials do not establish outcomes for Lina’s preparations, oral offerings or microdoses. Ask why the exact compounded option is proposed and what evidence supports it, rather than treating commercial benefit claims as demonstrated results.

Sources: [8] [7] [5] [1] [3] [4]

Questions & answers

Is Lina a physical med spa I can visit?

No physical office is advertised for patient visits. Lina describes a fully telehealth service serving all 50 states. Its terms nevertheless condition access on state-specific availability and require you to be physically in the same state as your account’s shipping address during consultation.

Sources: [12] [7]

Does $139 cover every Lina GLP-1 program?

No. That is the advertised starting price for Semaglutide Injection, not a universal quote. Tirzepatide Injection starts at $166/month, GLP-1 Microdose at $199/month and GLP-1 Oral at $229/month. Lina says pricing is confirmed after provider review; quantities and complete starting-price conditions still need confirmation.

Sources: [11] [8]

Can I take Lina’s prescription to my usual pharmacy?

Do not assume so. The terms say purchasing a service or product that includes a prescription waives pharmacy choice outside the pharmacies accessible through the platform. Ask Lina to identify the pharmacy and explain the restriction before purchasing if using your usual pharmacy is important to you.

Sources: [7]

How much notice does Lina require to cancel?

The public documents disagree: treatment pages specify 30 days before the next billing cycle, while the terms describe turning off portal auto-refill at least 48 hours before processing. Obtain written confirmation of the applicable deadline. Ending renewal does not automatically make services or processed medication refundable.

Sources: [12] [7]

Does Lina guarantee a prescription after the online form?

No. The five-to-ten-minute estimate concerns the intake form. The terms require consultation, a clinician’s determination of appropriateness and an issued prescription. The homepage says an unsuitable program will not generate a charge, but the timing of payment collection and that protection should be clarified before ordering.

Sources: [8] [7]

How can I contact Lina after enrollment?

Lina advertises direct clinician messaging through its secure patient portal. General contact is available at info@linaconciergemedspa.com, with support hours Monday–Saturday, 9 a.m.–6 p.m. Eastern. The contact form’s 24-hour response statement is a team-contact promise, not an established clinician response time or delivery guarantee.

Sources: [12] [10]

Our assessment

Lina provides a reasonably detailed description of its advertised service: remote intake, independent prescribing, compounded medication, portal messaging and home delivery, with visible starting prices for several programs. That gives prospective patients a useful basis for questions. It does not resolve the conflicting cancellation deadlines, unexplained contractual names, unidentified pharmacies or incomplete medicine details for the oral and microdose offerings. The strongest next step is a written, product-specific explanation covering the clinician, pharmacy, formulation, quantity, total charge, renewal date and cancellation rule. Clear answers would make comparison more meaningful; unresolved answers would leave substantial uncertainty before a recurring purchase. This documentary record supports preparing for a consultation, not endorsing a particular treatment or predicting its results.

Visit Lina Concierge Med Spa’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Lina Concierge Med Spa Review: Questions to Settle Before You Enroll

At a glance

01Start with who will actually be responsible for your care

02Ask for the medicine’s identity, not just the program name

03Clarify eligibility without treating the website as a prescription

04Separate a quick intake from a completed clinical evaluation

05Get the first charge and the recurring charge explained together

06Resolve cancellation before the next renewal becomes relevant

07Identify the pharmacy and plan for delivery problems

08Read privacy promises and clinical claims at their actual scope